We observed that the mRNA levels of MDM2 were significantly decreased in the methylated group compared to the unmethylated group in the HBV-related HCC patients and HCs (HBV-related HCC: p = 0.047; HCs: p = 0.005) (Figures 2C,D). This evidence concerns the gene MDM2 and hepatocellular carcinoma.